Top
LCE2D has not been detected as a mutational cancer driver

LCE2D
Ensembl id ENSG00000187223
Mutated samples
Coding Sequence 23 (0.3%)
Protein Affecting 19 (0.3%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all LCE2D gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Prostate adenocarcinoma No 3 3 1.23
Lung squamous cell carcinoma No 3 3 1.72
Cutaneous melanoma No 4 3 0.81
Lung adenocarcinoma No 3 2 0.51
Breast carcinoma No 2 2 0.17
Medulloblastoma No 1 1 0.48
Uterine corpus endometrioid carcinoma No 1 1 0.43
Non small cell lung carcinoma No 1 1 3.23
Stomach adenocarcinoma No 1 1 0.62
Head and neck squamous cell carcinoma No 1 1 0.27
Esophageal carcinoma No 2 1 0.68
Hepatocarcinoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence